1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Treating Mental Disorders Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Injection
1.2.5 Solution
1.2.6 Other
1.3 Market by Application
1.3.1 Global Drugs for Treating Mental Disorders Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Antipsychotics
1.3.3 Antidepressants
1.3.4 Antianxiety (Anxiolyitcs)
1.3.5 Anti-Seizure Medications
1.3.6 Stimulants
1.3.7 Cognitive Disorders And Dementia
1.3.8 Sleep Disorder Treatments
1.3.9 Substance Abuse Treatments
1.3.10 Hypnosis And Tranquilizers
1.3.11 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Treating Mental Disorders Market Perspective (2017-2028)
2.2 Drugs for Treating Mental Disorders Growth Trends by Region
2.2.1 Drugs for Treating Mental Disorders Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drugs for Treating Mental Disorders Historic Market Size by Region (2017-2022)
2.2.3 Drugs for Treating Mental Disorders Forecasted Market Size by Region (2023-2028)
2.3 Drugs for Treating Mental Disorders Market Dynamics
2.3.1 Drugs for Treating Mental Disorders Industry Trends
2.3.2 Drugs for Treating Mental Disorders Market Drivers
2.3.3 Drugs for Treating Mental Disorders Market Challenges
2.3.4 Drugs for Treating Mental Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Treating Mental Disorders Players by Revenue
3.1.1 Global Top Drugs for Treating Mental Disorders Players by Revenue (2017-2022)
3.1.2 Global Drugs for Treating Mental Disorders Revenue Market Share by Players (2017-2022)
3.2 Global Drugs for Treating Mental Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Treating Mental Disorders Revenue
3.4 Global Drugs for Treating Mental Disorders Market Concentration Ratio
3.4.1 Global Drugs for Treating Mental Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Treating Mental Disorders Revenue in 2021
3.5 Drugs for Treating Mental Disorders Key Players Head office and Area Served
3.6 Key Players Drugs for Treating Mental Disorders Product Solution and Service
3.7 Date of Enter into Drugs for Treating Mental Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Treating Mental Disorders Breakdown Data by Type
4.1 Global Drugs for Treating Mental Disorders Historic Market Size by Type (2017-2022)
4.2 Global Drugs for Treating Mental Disorders Forecasted Market Size by Type (2023-2028)
5 Drugs for Treating Mental Disorders Breakdown Data by Application
5.1 Global Drugs for Treating Mental Disorders Historic Market Size by Application (2017-2022)
5.2 Global Drugs for Treating Mental Disorders Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drugs for Treating Mental Disorders Market Size (2017-2028)
6.2 North America Drugs for Treating Mental Disorders Market Size by Type
6.2.1 North America Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
6.2.2 North America Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
6.2.3 North America Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
6.3 North America Drugs for Treating Mental Disorders Market Size by Application
6.3.1 North America Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
6.3.2 North America Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
6.3.3 North America Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
6.4 North America Drugs for Treating Mental Disorders Market Size by Country
6.4.1 North America Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
6.4.2 North America Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Drugs for Treating Mental Disorders Market Size (2017-2028)
7.2 Europe Drugs for Treating Mental Disorders Market Size by Type
7.2.1 Europe Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
7.2.2 Europe Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
7.2.3 Europe Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
7.3 Europe Drugs for Treating Mental Disorders Market Size by Application
7.3.1 Europe Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
7.3.2 Europe Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
7.3.3 Europe Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
7.4 Europe Drugs for Treating Mental Disorders Market Size by Country
7.4.1 Europe Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
7.4.2 Europe Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size (2017-2028)
8.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Type
8.2.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
8.3 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Application
8.3.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
8.4 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region
8.4.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drugs for Treating Mental Disorders Market Size (2017-2028)
9.2 Latin America Drugs for Treating Mental Disorders Market Size by Type
9.2.1 Latin America Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
9.2.2 Latin America Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
9.2.3 Latin America Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
9.3 Latin America Drugs for Treating Mental Disorders Market Size by Application
9.3.1 Latin America Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
9.3.2 Latin America Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
9.3.3 Latin America Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
9.4 Latin America Drugs for Treating Mental Disorders Market Size by Country
9.4.1 Latin America Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
9.4.2 Latin America Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size (2017-2028)
10.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type
10.2.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Drugs for Treating Mental Disorders Market Share by Type (2017-2028)
10.3 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application
10.3.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Drugs for Treating Mental Disorders Market Share by Application (2017-2028)
10.4 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country
10.4.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Introduction
11.1.4 Johnson and Johnson Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.1.5 Johnson and Johnson Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drugs for Treating Mental Disorders Introduction
11.2.4 Pfizer Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Drugs for Treating Mental Disorders Introduction
11.3.4 Eli Lilly Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.3.5 Eli Lilly Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Introduction
11.4.4 GlaxoSmithKline Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Drugs for Treating Mental Disorders Introduction
11.5.4 AstraZeneca Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.5.5 AstraZeneca Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Introduction
11.6.4 Bristol-Myers Squibb Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.7.4 Teva Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.7.5 Teva Pharmaceutical Recent Developments
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Details
11.8.2 Dr. Reddy's Laboratories Business Overview
11.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.8.5 Dr. Reddy's Laboratories Recent Developments
11.9 Apotex Inc.
11.9.1 Apotex Inc. Company Details
11.9.2 Apotex Inc. Business Overview
11.9.3 Apotex Inc. Drugs for Treating Mental Disorders Introduction
11.9.4 Apotex Inc. Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.9.5 Apotex Inc. Recent Developments
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Details
11.10.2 Mylan Pharmaceuticals Business Overview
11.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.10.4 Mylan Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.10.5 Mylan Pharmaceuticals Recent Developments
11.11 Par Pharmaceutical
11.11.1 Par Pharmaceutical Company Details
11.11.2 Par Pharmaceutical Business Overview
11.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.11.4 Par Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.11.5 Par Pharmaceutical Recent Developments
11.12 Aurobindo Pharma
11.12.1 Aurobindo Pharma Company Details
11.12.2 Aurobindo Pharma Business Overview
11.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Introduction
11.12.4 Aurobindo Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.12.5 Aurobindo Pharma Recent Developments
11.13 Torrent Pharmaceuticals
11.13.1 Torrent Pharmaceuticals Company Details
11.13.2 Torrent Pharmaceuticals Business Overview
11.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.13.4 Torrent Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.13.5 Torrent Pharmaceuticals Recent Developments
11.14 Jubilant Lifesciences
11.14.1 Jubilant Lifesciences Company Details
11.14.2 Jubilant Lifesciences Business Overview
11.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Introduction
11.14.4 Jubilant Lifesciences Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.14.5 Jubilant Lifesciences Recent Developments
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Details
11.15.2 Sun Pharmaceutical Business Overview
11.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.15.4 Sun Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.15.5 Sun Pharmaceutical Recent Developments
11.16 Sandoz (Novartis)
11.16.1 Sandoz (Novartis) Company Details
11.16.2 Sandoz (Novartis) Business Overview
11.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Introduction
11.16.4 Sandoz (Novartis) Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.16.5 Sandoz (Novartis) Recent Developments
11.17 Hansoh Pharmaceutical
11.17.1 Hansoh Pharmaceutical Company Details
11.17.2 Hansoh Pharmaceutical Business Overview
11.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.17.4 Hansoh Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.17.5 Hansoh Pharmaceutical Recent Developments
11.18 WATSON Pharmaceuticals
11.18.1 WATSON Pharmaceuticals Company Details
11.18.2 WATSON Pharmaceuticals Business Overview
11.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.18.4 WATSON Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.18.5 WATSON Pharmaceuticals Recent Developments
11.19 Zhejiang Langhua Pharmaceuticals
11.19.1 Zhejiang Langhua Pharmaceuticals Company Details
11.19.2 Zhejiang Langhua Pharmaceuticals Business Overview
11.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.19.4 Zhejiang Langhua Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.19.5 Zhejiang Langhua Pharmaceuticals Recent Developments
11.20 Forest Laboratories
11.20.1 Forest Laboratories Company Details
11.20.2 Forest Laboratories Business Overview
11.20.3 Forest Laboratories Drugs for Treating Mental Disorders Introduction
11.20.4 Forest Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.20.5 Forest Laboratories Recent Developments
11.21 H.Lundbeck A/S
11.21.1 H.Lundbeck A/S Company Details
11.21.2 H.Lundbeck A/S Business Overview
11.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Introduction
11.21.4 H.Lundbeck A/S Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.21.5 H.Lundbeck A/S Recent Developments
11.22 Amneal Pharmaceuticals
11.22.1 Amneal Pharmaceuticals Company Details
11.22.2 Amneal Pharmaceuticals Business Overview
11.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.22.4 Amneal Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.22.5 Amneal Pharmaceuticals Recent Developments
11.23 Hetero Drugs
11.23.1 Hetero Drugs Company Details
11.23.2 Hetero Drugs Business Overview
11.23.3 Hetero Drugs Drugs for Treating Mental Disorders Introduction
11.23.4 Hetero Drugs Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.23.5 Hetero Drugs Recent Developments
11.24 Macleods Pharmaceuticals
11.24.1 Macleods Pharmaceuticals Company Details
11.24.2 Macleods Pharmaceuticals Business Overview
11.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.24.4 Macleods Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.24.5 Macleods Pharmaceuticals Recent Developments
11.25 Silarx Pharmacueticals
11.25.1 Silarx Pharmacueticals Company Details
11.25.2 Silarx Pharmacueticals Business Overview
11.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Introduction
11.25.4 Silarx Pharmacueticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.25.5 Silarx Pharmacueticals Recent Developments
11.26 Hikma Pharmaceuticals
11.26.1 Hikma Pharmaceuticals Company Details
11.26.2 Hikma Pharmaceuticals Business Overview
11.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Introduction
11.26.4 Hikma Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.26.5 Hikma Pharmaceuticals Recent Developments
11.27 Lupin Limited
11.27.1 Lupin Limited Company Details
11.27.2 Lupin Limited Business Overview
11.27.3 Lupin Limited Drugs for Treating Mental Disorders Introduction
11.27.4 Lupin Limited Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.27.5 Lupin Limited Recent Developments
11.28 Prinston Pharmaceutical
11.28.1 Prinston Pharmaceutical Company Details
11.28.2 Prinston Pharmaceutical Business Overview
11.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Introduction
11.28.4 Prinston Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.28.5 Prinston Pharmaceutical Recent Developments
11.29 STI Pharma
11.29.1 STI Pharma Company Details
11.29.2 STI Pharma Business Overview
11.29.3 STI Pharma Drugs for Treating Mental Disorders Introduction
11.29.4 STI Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022)
11.29.5 STI Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
